MindsEye Enterprises
  • Home
  • About
  • Services
  • The Wellness Enclave
    • Opioid Overdose Crisis
    • Overcoming Negative Messages
    • Understanding Grief and Loss
    • A to Zen of Life
    • Cancer: Coping With Uncertainty
    • Cancer: Fear of Treatment-Related Side Effects
    • Caregiver Stress and Burnout
    • Diet and Mental Health
  • MM & CC
    • Meditative Messages
    • Compelling Conversations >
      • Assisted Living: How to have “The Talk” with Your Parents
  • Contact
  • Forms
    • Workshop Inquiry Form
    • Workshop Evaluation Form
  • Advertise
  • Download the App (Mobile Only)
  • Home
  • About
  • Services
  • The Wellness Enclave
    • Opioid Overdose Crisis
    • Overcoming Negative Messages
    • Understanding Grief and Loss
    • A to Zen of Life
    • Cancer: Coping With Uncertainty
    • Cancer: Fear of Treatment-Related Side Effects
    • Caregiver Stress and Burnout
    • Diet and Mental Health
  • MM & CC
    • Meditative Messages
    • Compelling Conversations >
      • Assisted Living: How to have “The Talk” with Your Parents
  • Contact
  • Forms
    • Workshop Inquiry Form
    • Workshop Evaluation Form
  • Advertise
  • Download the App (Mobile Only)
Search by typing & pressing enter

YOUR CART

Opioid Overdose Crisis

Picture
Revised March 2018
Every day, more than 115 people in the United States die after overdosing on opioids.1 The misuse of and addiction to opioids—including prescription pain relievers, heroin, and synthetic opioids such as fentanyl—is a serious national crisis that affects public health as well as social and economic welfare. The Centers for Disease Control and Prevention estimates that the total "economic burden" of prescription opioid misuse alone in the United States is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction treatment, and criminal justice involvement.2

How did this happen?

​In the late 1990s, pharmaceutical companies reassured the medical community that patients would not become addicted to prescription opioid pain relievers, and healthcare providers began to prescribe them at greater rates. This subsequently led to widespread diversion and misuse of these medications before it became clear that these medications could indeed be highly addictive.3,4 Opioid overdose rates began to increase. In 2015, more than 33,000 Americans died as a result of an opioid overdose, including prescription opioids, heroin, and illicitly manufactured fentanyl, a powerful synthetic opioid.1 That same year, an estimated 2 million people in the United States suffered from substance use disorders related to prescription opioid pain relievers, and 591,000 suffered from a heroin use disorder (not mutually exclusive).5

What do we know about the opioid crisis?
  • Roughly 21 to 29 percent of patients prescribed opioids for chronic pain misuse them.6
  • Between 8 and 12 percent develop an opioid use disorder.7–9
  • An estimated 4 to 6 percent who misuse prescription opioids transition to heroin.7–9
  • About 80 percent of people who use heroin first misused prescription opioids.7
  • Opioid overdoses increased 30 percent from July 2016 through September 2017 in 52 areas in 45 states.10
  • The Midwestern region saw opioid overdoses increase 70 percent from July 2016 through September 2017.10
  • Opioid overdoses in large cities increase by 54 percent in 16 states.10​

Picture


Quarterly rate of suspected opioid overdose, by US region

Source: Centers for Disease Control and Prevention.10


This issue has become a public health crisis with devastating consequences including increases in opioid misuse and related overdoses, as well as the rising incidence of neonatal abstinence syndrome due to opioid use and misuse during pregnancy. The increase in injection drug use has also contributed to the spread of infectious diseases including HIV and hepatitis C. As seen throughout the history of medicine, science can be an important part of the solution in resolving such a public health crisis.

What are HHS and NIH doing about it?
​

I​n response to the opioid crisis, the U.S. Department of Health and Human Services (HHS) is focusing its efforts on
five major priorities:
  1. improving access to treatment and recovery services
  2. promoting use of overdose-reversing drugs
  3. strengthening our understanding of the epidemic through better public health surveillance
  4. providing support for cutting-edge research on pain and addiction
  5. advancing better practices for pain management

The National Institutes of Health (NIH), a component of HHS, is the nation's leading medical research agency helping solve the opioid crisis via discovering new and better ways to prevent opioid misuse, treat opioid use disorders, and manage pain. In the summer of 2017, NIH met with pharmaceutical companies and academic research centers to discuss:
​
  1. safe, effective, non-addictive strategies to manage chronic pain
  2. new, innovative medications and technologies to treat opioid use disorders
  3. improved overdose prevention and reversal interventions to save lives and support recovery

In April 2018 at the National Rx Drug Abuse and Heroin Summit, NIH Director Francis S. Collins, M.D., Ph.D., announced the launch of the HEAL (Helping to End Addiction Long-term) Initiative, an aggressive, trans-agency effort to speed scientific solutions to stem the national opioid public health crisis. 

Article reprinted from the National Institute on Drug Abuse
​

MIND'S EYE ENTERPRISES

Our Mission
“To increase positivity and productivity within individuals, groups, and organizations through education and development"

Mind’s Eye Enterprises, LLC (MEE, LLC) provides psycho-educational seminars/workshops and program consultation. MEE’s goal is to equip our clients with the tools needed to become more productive and efficient in both the workplace and daily living. We offer a number of seminars that reflect common areas of concern for individuals, groups and organizations. The common goals for each of our seminars are to: increase motivation, decrease stress and negative behaviors, maximize efficiency and productivity, and encourage positive and proactive behavior.
Disclaimer
The information and opinions expressed on this website, the broadcasts, and social media outlets are intended to address specific questions asked, situations described in the program or on the website, and topics of expressed interest. The information and/or opinions are not designed to constitute advice re: Mental Health Diagnosis and/or specific life situation(s). You should not act or rely upon any information contained in these broadcasts or on the website without seeking the advice of a Licensed Mental Health Professional, who has conducted a formal assessment or evaluation on you; and has the requisite information needed to provide a more well informed opinion. This includes, but is not limited to LCSWs, LMFTs, LPCs, LMHCs, PsyD, and Psychiatrists. If you have any questions about the information or opinions expressed on the website or during the broadcasts, please contact your Licensed Mental Health Professional.

Privacy Policy

 Last updated: 01/31/2021

MEEnterprises  operates http://www.meenterprises.net (the "Site") and The Wellness Enclave (the "App). This page informs you of our policies regarding the collection, use and disclosure of Personal Information we receive from users of the Site.  We use your Personal Information only for providing and improving the Site. By using the Site, you agree to the collection and use of information in accordance with this policy.
Information Collection And Use
While using our Site, we may ask you to provide us with certain personally identifiable information that can be used to contact or identify you. Personally identifiable information may include, but is not limited to your name ("Personal Information").
Log Data
Like many site operators, we collect information that your browser sends whenever you visit our Site ("Log Data").  This Log Data may include information such as your computer's Internet Protocol ("IP") address, browser type, browser version, the pages of our Site that you visit, the time and date of your visit, the time spent on those pages and other statistics. In addition, we may use third party services such as Google Analytics that collect, monitor and analyze this …
Communications
Users are not required to provide their names or other personally identifiable information in order to view the site.  The site is for informational purposes.
Cookies
Cookies are files with small amount of data, which may include an anonymous unique identifier. Cookies are sent to your browser from a web site and stored on your computer's hard drive.  Like many sites, we use "cookies" to collect information. You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our Site. 
Security
The security of your Personal Information is important to us, but remember that no method of transmission over the Internet, or method of electronic storage, is 100% secure. While we strive to use commercially acceptable means to protect your Personal Information, we cannot guarantee its absolute security.
Changes To This Privacy Policy
This Privacy Policy is effective as of 01/31/21 and will remain in effect except with respect to any changes in its provisions in the future, which will be in effect immediately after being posted on this page.

We reserve the right to update or change our Privacy Policy at any time and you should check this Privacy Policy periodically. Your continued use of the Service after we post any modifications to the Privacy Policy on this page will constitute your acknowledgment of the modifications and your consent to abide and be bound by the modified Privacy Policy.  If we make any material changes to this Privacy Policy, we will notify you either through the email address you have provided us, or by placing a prominent notice on our website.

Contact

Business Address:
260 Peachtree St., NW
Suite 2200
Atlanta, GA 30303
​Business Phone:
(404) 245-1344
Email:
info@meenterprises.net
We accept payments through PayPal - Major Credit Cards
Picture
Connect with us on Social Media
MIND'S EYE ENTERPRISES © COPYRIGHT 2018 ALL RIGHTS RESERVED.